Icecure Medical
IceCure Medical Ltd, a commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers ProSense system, a single probe system for the treatment of malignant breast tumors, as well as associated disposables; and IceSense3 syst… Read more
Icecure Medical (ICCM) - Total Liabilities
Latest total liabilities as of September 2025: $5.77 Million USD
Based on the latest financial reports, Icecure Medical (ICCM) has total liabilities worth $5.77 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Icecure Medical - Total Liabilities Trend (2014–2024)
This chart illustrates how Icecure Medical's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Icecure Medical Competitors by Total Liabilities
The table below lists competitors of Icecure Medical ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SRV Group plc
HE:SRV1V
|
Finland | €377.80 Million |
|
Poznanska Korporacja Budowlana Pekabex SA
WAR:PBX
|
Poland | zł982.70 Million |
|
Jasper Therapeutics Inc
NASDAQ:JSPR
|
USA | $45.90 Million |
|
Synergy Green Industries Limited
NSE:SGIL
|
India | ₹2.91 Billion |
|
Everyday People Financial Corp.
V:EPF
|
Canada | CA$58.09 Million |
|
Excellon Resources Inc
PINK:EXNRF
|
USA | $24.59 Million |
|
Ecos India Mobility & Hospitality Ltd
NSE:ECOSMOBLTY
|
India | ₹1.37 Billion |
|
Xtant Medical Holdings Inc
NYSE MKT:XTNT
|
USA | $55.94 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down Icecure Medical's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Icecure Medical's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Icecure Medical (2014–2024)
The table below shows the annual total liabilities of Icecure Medical from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $5.67 Million | +33.62% |
| 2023-12-31 | $4.25 Million | -10.89% |
| 2022-12-31 | $4.77 Million | -10.46% |
| 2021-12-31 | $5.32 Million | -7.49% |
| 2020-12-31 | $5.75 Million | +22.66% |
| 2019-12-31 | $4.69 Million | +148.57% |
| 2018-12-31 | $1.89 Million | -13.75% |
| 2017-12-31 | $2.19 Million | +80.85% |
| 2016-12-31 | $1.21 Million | +0.66% |
| 2015-12-31 | $1.20 Million | -17.90% |
| 2014-12-31 | $1.46 Million | -- |